Foxstone has completed a CHF 10 million Series A financing round. The online platform is a fast growing real estate crowdfunding that democratizes real investment through technology and has attracted new investors including the Swiss family office Rosablanche Ventures. Allmost all existing investors joined the round. The family investment vehicle of Thierry Baudon, founder of […]
UBS Switzerland has participated as well as other Banks together with Nova Property Fund Management on the refinancing and further supporting development of the Klybeckareal Project in Basel city. UBS has acted as mandated lead
Vantage Education Group, one of the leading providers of education and training in Switzerland, has completed an extensive refinancing, with UBS Switzerland acting as mandated lead arranger, agent, security agent and original lender, and Berner
The Swiss pharmaceutical BioVersys has raised CHF 24.2 million in a first closing of its Series C round. This first closing was significantly oversubscribed by both existing and new investors from diverse geographies. The company intends
ImmunOs Therapeutics has closed an oversubscribed Series B financing round totaling USD 74 million. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by new investors Mission BioCapital, GL
After its successful product launch in September 2021, Swiss fintech start-up Numerics has just closed a CHF 2.1 million pre-seed financing round led by Wingman Ventures and Seed X Liechtenstein. Numarics is Zurich based start-up that offers
GP Investments, majority shareholder of Spice Private Equity, has pre-announced its public tender offer for all publicly held shares in SIX listed Spice Private Equity. GP Investments intends to increase its equity share in Spice
Junod, Muhlstein, Lévy & Puder advised Barcelona-based hospitality recruitment platform Hosco on a successful EUR 3,400,000 intermediate Series-A financing round for hospitality network. Created in 2011 the hospitality recruitment platform Hosco is aimed at companies
Perfect Holding announced the completion of the reverse takeover transaction (RTO) with Kinarus, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic disease.
Engimmune Therapeutics, a Swiss biotech company based in Basel developing novel T-cell receptor (TCR)-based therapeutics, has closed a CHF 15.5m seed financing round. The round was led by the investors Pureos Bio-ventures and Novo
